$70.60
1.43% yesterday
Nasdaq, Sep 03, 10:00 pm CET
ISIN
US46266A1097
Symbol
IRMD

iRadimed Corp Stock price

$70.60
-0.09 0.13% 1M
+17.31 32.48% 6M
+15.60 28.36% YTD
+24.78 54.08% 1Y
+39.52 127.19% 3Y
+50.18 245.82% 5Y
+47.98 212.15% 10Y
+61.29 658.00% 20Y
Nasdaq, Closing price Wed, Sep 03 2025
-1.03 1.43%

Key metrics

Basic
Market capitalization
$911.1m
Enterprise Value
$858.1m
Net debt
positive
Cash
$53.0m
Shares outstanding
12.7m
Valuation (TTM | estimate)
P/E
44.5 | 38.0
P/S
11.7 | 10.9
EV/Sales
11.1 | 10.3
EV/FCF
64.4
P/B
9.7
Dividends
DPS
$1.67
Yield 1Y | 5Y
0.2% | 0.1%
Growth 1Y | 5Y
100.0% | -
Payout 1Y | 3Y
123.6% | 84.5%
Increased
2 Years
Financials (TTM | estimate)
Revenue
$77.6m | $83.3m
EBITDA
$24.6m | -
EBIT
$23.8m | $25.4m
Net Income
$20.7m | $24.0m
Free Cash Flow
$13.3m
Growth (TTM | estimate)
Revenue
11.7% | 13.8%
EBITDA
10.5% | -
EBIT
11.0% | 15.5%
Net Income
10.8% | 24.8%
Free Cash Flow
2.5%
Margin (TTM | estimate)
Gross
77.0%
EBITDA
31.7% | -
EBIT
30.7%
Net
26.6% | 28.8%
Free Cash Flow
17.2%
Financial Health
Equity Ratio
88.3%
Return on Equity
22.2%
ROCE
24.4%
ROIC
39.2%
Debt/Equity
0.0
More
EPS
$1.6
FCF per Share
$1.0
Short interest
2.4%
Employees
160
Rev per Employee
$460.0k
Show more

Is iRadimed Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

iRadimed Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a iRadimed Corp forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a iRadimed Corp forecast:

Buy
88%
Hold
13%

Financial data from iRadimed Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
78 78
12% 12%
100%
- Direct Costs 18 18
13% 13%
23%
60 60
11% 11%
77%
- Selling and Administrative Expenses 33 33
25% 25%
43%
- Research and Development Expense 2.71 2.71
53% 53%
3%
25 25
10% 10%
32%
- Depreciation and Amortization 0.79 0.79
4% 4%
1%
EBIT (Operating Income) EBIT 24 24
11% 11%
31%
Net Profit 21 21
11% 11%
27%

In millions USD.

Don't miss a Thing! We will send you all news about iRadimed Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

iRadimed Corp Stock News

Neutral
GlobeNewsWire
8 days ago
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, today announced that it will participate in the Wells Fargo 2025 Healthcare Conference, held September 3-5, 2025, in Boston, Massachusetts.
Positive
Seeking Alpha
13 days ago
IRadimed Corporation demonstrates exceptional economic characteristics, with high NOPAT margins, robust free cash flow, and consistent value creation for shareholders. Management has effectively reinvested capital, generating over $18 in market value for every $1 invested since FY'22, and consistently exceeding a 12% ROIC hurdle rate. Despite modest sales growth, IRMD's profitability and cash c...
Positive
The Motley Fool
about one month ago
Iradimed (IRMD) Q2 Revenue Jumps 14%
More iRadimed Corp News

Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Head office United States
CEO Roger Susi
Employees 160
Founded 1992
Website www.iradimed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today